Selected research
Industry Research
Human Rabies Vaccine Antibody Testing Service Industry Research Report 2026
Market perspective
The global Human Rabies Vaccine Antibody Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Human Rabies Vaccine Antibody Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Human Rabies Vaccine Antibody Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Human Rabies Vaccine Antibody Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Human Rabies Vaccine Antibody Testing Service include CVRL, Labcorp, Pasteur Institute, Swedish Veterinary Agency, Kansas State Veterinary Diagnostic Laboratory, A&M Veterinary Medical Diagnostic Laboratory, Institute of Virology and Immunology IVI, Wuhan Institute of Virology, CAS and Huayin Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Human Rabies Vaccine Antibody Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Human Rabies Vaccine Antibody Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Rabies Vaccine Antibody Testing Service Market by Company
CVRL
Labcorp
Pasteur Institute
Swedish Veterinary Agency
Kansas State Veterinary Diagnostic Laboratory
A&M Veterinary Medical Diagnostic Laboratory
Institute of Virology and Immunology IVI
Wuhan Institute of Virology, CAS
Huayin Health
Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical
Changchun Veterinary Research Institute
Human Rabies Vaccine Antibody Testing Service Segment by Type
MNT
RFFIT
Human Rabies Vaccine Antibody Testing Service Segment by Application
Public Health
Biological Products
Others
Human Rabies Vaccine Antibody Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine Antibody Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine Antibody Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine Antibody Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Human Rabies Vaccine Antibody Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- MNT
- RFFIT
Applications
- Public Health
- Biological Products
- Others
Companies covered
- CVRL
- Labcorp
- Pasteur Institute
- Swedish Veterinary Agency
- Kansas State Veterinary Diagnostic Laboratory
- A&M Veterinary Medical Diagnostic Laboratory
- Institute of Virology and Immunology IVI
- Wuhan Institute of Virology, CAS
- Huayin Health
- Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical
- Changchun Veterinary Research Institute
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Human Rabies Vaccine Antibody Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 MNT
- 2.2.3 RFFIT
- 2.3 Human Rabies Vaccine Antibody Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Public Health
- 2.3.3 Biological Products
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Human Rabies Vaccine Antibody Testing Service Breakdown Data by Type
- 3.1 Global Human Rabies Vaccine Antibody Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Human Rabies Vaccine Antibody Testing Service Forecasted Market Size by Type (2027-2032)
4 Human Rabies Vaccine Antibody Testing Service Breakdown Data by Application
- 4.1 Global Human Rabies Vaccine Antibody Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Human Rabies Vaccine Antibody Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Human Rabies Vaccine Antibody Testing Service Market Perspective (2021-2032)
- 5.2 Global Human Rabies Vaccine Antibody Testing Service Growth Trends by Region
- 5.2.1 Global Human Rabies Vaccine Antibody Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Human Rabies Vaccine Antibody Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Human Rabies Vaccine Antibody Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Human Rabies Vaccine Antibody Testing Service Market Dynamics
- 5.3.1 Human Rabies Vaccine Antibody Testing Service Industry Trends
- 5.3.2 Human Rabies Vaccine Antibody Testing Service Market Drivers
- 5.3.3 Human Rabies Vaccine Antibody Testing Service Market Challenges
- 5.3.4 Human Rabies Vaccine Antibody Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Human Rabies Vaccine Antibody Testing Service Players by Revenue
- 6.1.1 Global Top Human Rabies Vaccine Antibody Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Human Rabies Vaccine Antibody Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Human Rabies Vaccine Antibody Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Human Rabies Vaccine Antibody Testing Service Head Office and Area Served
- 6.4 Global Human Rabies Vaccine Antibody Testing Service Players, Product Type & Application
- 6.5 Global Human Rabies Vaccine Antibody Testing Service Manufacturers Established Date
- 6.6 Global Human Rabies Vaccine Antibody Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Human Rabies Vaccine Antibody Testing Service Market Size (2021-2032)
- 7.2 North America Human Rabies Vaccine Antibody Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Human Rabies Vaccine Antibody Testing Service Market Size by Country (2021-2026)
- 7.4 North America Human Rabies Vaccine Antibody Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Human Rabies Vaccine Antibody Testing Service Market Size (2021-2032)
- 8.2 Europe Human Rabies Vaccine Antibody Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Human Rabies Vaccine Antibody Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Human Rabies Vaccine Antibody Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Human Rabies Vaccine Antibody Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Human Rabies Vaccine Antibody Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Human Rabies Vaccine Antibody Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Human Rabies Vaccine Antibody Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Human Rabies Vaccine Antibody Testing Service Market Size (2021-2032)
- 10.2 South America Human Rabies Vaccine Antibody Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Human Rabies Vaccine Antibody Testing Service Market Size by Country (2021-2026)
- 10.4 South America Human Rabies Vaccine Antibody Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Human Rabies Vaccine Antibody Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Human Rabies Vaccine Antibody Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Human Rabies Vaccine Antibody Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Human Rabies Vaccine Antibody Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CVRL
- 12.1.1 CVRL Company Information
- 12.1.2 CVRL Business Overview
- 12.1.3 CVRL Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.1.4 CVRL Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.1.5 CVRL Recent Developments
- 12.2 Labcorp
- 12.2.1 Labcorp Company Information
- 12.2.2 Labcorp Business Overview
- 12.2.3 Labcorp Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.2.4 Labcorp Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.2.5 Labcorp Recent Developments
- 12.3 Pasteur Institute
- 12.3.1 Pasteur Institute Company Information
- 12.3.2 Pasteur Institute Business Overview
- 12.3.3 Pasteur Institute Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.3.4 Pasteur Institute Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.3.5 Pasteur Institute Recent Developments
- 12.4 Swedish Veterinary Agency
- 12.4.1 Swedish Veterinary Agency Company Information
- 12.4.2 Swedish Veterinary Agency Business Overview
- 12.4.3 Swedish Veterinary Agency Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.4.4 Swedish Veterinary Agency Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.4.5 Swedish Veterinary Agency Recent Developments
- 12.5 Kansas State Veterinary Diagnostic Laboratory
- 12.5.1 Kansas State Veterinary Diagnostic Laboratory Company Information
- 12.5.2 Kansas State Veterinary Diagnostic Laboratory Business Overview
- 12.5.3 Kansas State Veterinary Diagnostic Laboratory Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.5.4 Kansas State Veterinary Diagnostic Laboratory Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.5.5 Kansas State Veterinary Diagnostic Laboratory Recent Developments
- 12.6 A&M Veterinary Medical Diagnostic Laboratory
- 12.6.1 A&M Veterinary Medical Diagnostic Laboratory Company Information
- 12.6.2 A&M Veterinary Medical Diagnostic Laboratory Business Overview
- 12.6.3 A&M Veterinary Medical Diagnostic Laboratory Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.6.4 A&M Veterinary Medical Diagnostic Laboratory Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.6.5 A&M Veterinary Medical Diagnostic Laboratory Recent Developments
- 12.7 Institute of Virology and Immunology IVI
- 12.7.1 Institute of Virology and Immunology IVI Company Information
- 12.7.2 Institute of Virology and Immunology IVI Business Overview
- 12.7.3 Institute of Virology and Immunology IVI Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.7.4 Institute of Virology and Immunology IVI Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.7.5 Institute of Virology and Immunology IVI Recent Developments
- 12.8 Wuhan Institute of Virology, CAS
- 12.8.1 Wuhan Institute of Virology, CAS Company Information
- 12.8.2 Wuhan Institute of Virology, CAS Business Overview
- 12.8.3 Wuhan Institute of Virology, CAS Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.8.4 Wuhan Institute of Virology, CAS Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.8.5 Wuhan Institute of Virology, CAS Recent Developments
- 12.9 Huayin Health
- 12.9.1 Huayin Health Company Information
- 12.9.2 Huayin Health Business Overview
- 12.9.3 Huayin Health Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.9.4 Huayin Health Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.9.5 Huayin Health Recent Developments
- 12.10 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical
- 12.10.1 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical Company Information
- 12.10.2 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical Business Overview
- 12.10.3 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.10.4 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.10.5 Laboratory for Rabies Antibody Assay SinoTech World Biologicals (Beijing) Pharmaceutical Recent Developments
- 12.11 Changchun Veterinary Research Institute
- 12.11.1 Changchun Veterinary Research Institute Company Information
- 12.11.2 Changchun Veterinary Research Institute Business Overview
- 12.11.3 Changchun Veterinary Research Institute Revenue in Human Rabies Vaccine Antibody Testing Service Business (2021-2026)
- 12.11.4 Changchun Veterinary Research Institute Human Rabies Vaccine Antibody Testing Service Product Portfolio
- 12.11.5 Changchun Veterinary Research Institute Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst